NCT02609828 2023-02-16
Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy
Pfizer
Phase 3 Completed
Pfizer
InSightec
H. Lee Moffitt Cancer Center and Research Institute